The U.S. Food and Drug Administration (FDA) has granted authorization to the updated Novavax COVID-19 vaccine, allowing it to protect against hospitalization and death from circulating variants. This protein-based shot, targeting the XBB.1.5 strain as required by the FDA, serves as a non-mRNA option for the upcoming 2023-2024 season. The authorization comes after the FDA’s
0 Comments
The stock market experienced a significant decline on Tuesday as traders grew increasingly concerned about rising Treasury yields, which reached a 16-year high. The Dow Jones Industrial Average plummeted by 345 points, equivalent to a 1% decrease. Similarly, the S&P 500 and Nasdaq Composite both slid, experiencing declines of 1.1% and 1.5% respectively. The drop
0 Comments